Stay updated on BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page.

Latest updates to the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check18 days agoChange DetectedNew study sites added: Helsinki, Finland, 00290; Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E.; Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E. The Helsinki site 00029 HUS and the generic Instituto Portugues de Oncologia affiliation were removed.SummaryDifference0.2%

- Check26 days agoChange DetectedDifference0.1%

- Check33 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the 'MedlinePlus Genetics' topic from the study's metadata. This changes the disease-related keywords associated with the page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe recruitment site was updated to add Aarhus N (8200) and remove Aarhus C (8000); related topics 'Multiple myeloma' and 'MedlinePlus Genetics' were added.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice and operating status message (Revision: v3.4.1); these changes are peripheral to the trial details and do not affect study data or eligibility, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedNotice: government funding lapse banner added to the page, and the site revision updated to v3.4.1. Removed 'Multiple myeloma' and related topics 'MedlinePlus Genetics' (and prior revision note 'v3.4.0'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR-T vs VRd in Newly Diagnosed MM Clinical Trial page.